Regarding immune inhibitors, IDO-1 regulates the immune response via NF-κB; CD276 can help promote pancreatic carcinoma metastasis and infiltration by activating the TLR4–NF-κB signaling pathway, via upregulated expression of IL-8 and VEGF. Here, TLR4 is linked to exocrine pancreatic carcinoma.